EASTBOURNE CAPITAL MANAGEMENT LLC/CA

CIK 1140888 · last filed 2010-05-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$431.50M

Companies

5

Total Filings

41

Lifetime Open-Market Net

-$212.14M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted 10%+ Owner 1,696,646 -$6.02M 13 2010-05-12
Sarepta Therapeutics, Inc. (AVII) Delisted 10%+ Owner 943,202 -$5.55M 2 2010-03-08
CASSAVA SCIENCES INC (PTIE) Delisted 10%+ Owner 3,265,627 -$33.56M 9 2009-09-29
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted 10%+ Owner 15,919,863 -$95.50M 15 2009-09-18
MTG 10%+ Owner 14,900,000 $28.96 $431.50M -$71.50M 2 2009-09-16

Recent Filings · Page 5 of 5

41 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2008-02-29 CASSAVA SCIENCES INC (PTIE) Delisted Buy (P) +174,700 $1.59M EDGAR
Showing 4141 of 41
Page 5 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.